{"name":"Takeda Research Investment","permalink":"takeda-research-investment","crunchbase_url":"http://www.crunchbase.com/financial-organization/takeda-research-investment","homepage_url":"http://www.tri-takeda.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"1-650-328-2900","description":"","email_address":"contact@tri-takeda.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"TRI","created_at":"Wed Apr 21 03:35:36 UTC 2010","updated_at":"Wed Apr 21 03:47:13 UTC 2010","overview":"<p>Takeda Research Investment (TRI) is the corporate venture arm of Takeda Pharmaceutical Company Limited (TPC) a world-class pharmaceutical company and the largest in Japan. A wholly-owned subsidiary of Takeda America Holdings, Inc., TRI started operations in November 2001. Their aim is to encourage and support therapeutic innovation in biopharmaceutical companies and academic centers of excellence, through early stage capital investment and provision of access to the resources of a multinational pharmaceutical company.</p>","image":{"available_sizes":[[[89,45],"assets/images/resized/0008/4399/84399v1-max-150x150.jpg"],[[89,45],"assets/images/resized/0008/4399/84399v1-max-250x250.jpg"],[[89,45],"assets/images/resized/0008/4399/84399v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"435 Tasso Street, Suite 300","address2":"","zip_code":"94301","city":"Palo Alto","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"d","source_url":"http://bulletin.sciencebusiness.net/sb/login.php?page=/ebulletins/showissue.php3?page=/548/art/4700","source_description":"Symphogen gets $25M for clinical trials for bleeding treatment","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":10,"company":{"name":"Symphogen","permalink":"symphogen","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/1671/41671v1-max-150x150.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-250x250.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.lectustherapeutics.com/PR_13%20February%202006.html","source_description":"Lectus Therapeutics closes Series A funding round raising Â£8.2 million","raised_amount":8200000,"raised_currency_code":"GBP","funded_year":2006,"funded_month":2,"funded_day":13,"company":{"name":"Lectus Therapeutics","permalink":"lectus-therapeutics","image":{"available_sizes":[[[150,53],"assets/images/resized/0008/0510/80510v1-max-150x150.jpg"],[[183,65],"assets/images/resized/0008/0510/80510v1-max-250x250.jpg"],[[183,65],"assets/images/resized/0008/0510/80510v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}